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Biomaterial-associated infectionsSince most antibacterial coatings reported to fight biomaterial-associated infections (BAI) fail in com-
pletely preventing bacterial colonization, it is crucial to know the impact of that small fraction of adhered
bacteria in BAI recrudescence. This study aims to understand the fate of Staphylococcus aureus able to
adhere to an antimicrobial coating previously developed, in terms of potential development of bacterial
resistance and their macrophage-mediated phagocytosis. Antimicrobial coating comprised the co-
immobilization of Palm peptide and DNase I onto polydimethylsiloxane. Expression of genes associated
to resistance and virulence mechanisms showed that cells in contact with antimicrobial surfaces for a
long period of 30 days, exhibit genes equally or less expressed, as compared to cells recovered from con-
trol surfaces. Recovered cells also exhibit the same susceptibility patterns, which strengthens the evi-
dence of no resistance development. Remarkably, cells adhered to modified surfaces shows a reduced
metabolic activity upon vancomycin treatment unlike the cells found on control surfaces, which can
be identified as a clinical opportunity for prophylactically administration after implant surgery.
Furthermore, results highlight that functionalization of PDMS with Palm and DNase I should not compro-
mise the action of host immune cells. The overall results reinforce the potential of this antimicrobial
strategy to fight BAI.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Polydimethylsiloxane (PDMS), commonly referred as silicone
rubber, is used for a wide variety of biomedical applications due
to its excellent biocompatibility and mechanical properties. For
instance, it has been used in vascular grafts [1], catheters [2], stents
[3], breast implants [4] and voice prostheses [5]. However, PDMS-
based biomedical devices are prone to microbial adhesion which
can be a prelude for biofilm formation and infection. Biofilm-
associated infections are extremely difficult to eradicate because
cells within a biofilm encase themselves in a self-produced matrix
which confers them protection against antimicrobial treatment
and host immune system [6,7]. Very often, the only solution for
an infected implant relies on its surgical removal at the expenses
of considerable costs and patient suffering. Moreover, the removal
of the infected implant may not completely solve the problem dueto the pathogen burden remaining in the body which is responsible
for recurrent infection [8].
Several strategies to modify PDMS surface have been reported
to prevent bacterial colonisation. For example, silicone catheters
have been impregnated with antibiotics such as minocycline/
rifampin [9], triclosan [10] and nitrofuzane [11]. Although this
approach proved to prevent bacterial adhesion and biofilm forma-
tion on these surface-coated catheters, there are some drawbacks
that limit their clinical application, mainly their short-term
antibacterial effect and the potential development of bacterial
resistance [12]. An alternative approach relies on the use of silver
or silver nanoparticles to coat the surfaces of catheters, but its
potential has been compromised by the high cost of the silver coat-
ings and the conflicting clinical results regarding silver safety [13].
Covalent immobilization of antimicrobials offers an alternative
approach that avoids patient exposure to leaching compounds
and potentially increases the duration of antimicrobial efficacy
[14]. This strategy should be employed with antimicrobial agents
working at the level of the cell wall or membrane, since they can
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nium silane, antimicrobial peptides (AMP) and enzymes targeting
the components of biofilms matrix are examples of commonly
used antimicrobial agents that have been covalently immobilized
onto PDMS surfaces to prevent BAI [14–16]. Although the results
obtained with these strategies have been encouraging, there are
some challenges in the field of antibacterial coatings that urgently
need to be solved so they can be applied in clinical practice.
An important issue is associated to the fact that most of the
coatings reported in the literature are not able to completely pre-
vent bacterial adhesion. Therefore, it is crucial to determine if the
‘‘few” bacteria that manage to adhere to these coatings are able
to grow into a mature biofilm. For instance, Nejadnik et al. have
demonstrated the ability of few bacteria that adhered on a polymer
brush-coating to form a weakly adhering biofilm [17]. Another
challenge is the potential development of microbial resistance
towards the antimicrobials released from the surfaces. Although
antimicrobials permanent immobilization has been proposed as
an alternative approach to minimize antimicrobial resistance
development, because covalent immobilization avoids exposure
to sub-inhibitory concentrations [18,19], there is a lack of studies
addressing these issues.
Another crucial factor influencing the pathogenesis of BAI, often
neglected in the field of antibacterial coatings, is the role of host’s
immune system. Once a BAI is established, different immune cells
are recruited to the infection site but macrophages end up being
the prevailing cells responsible to orchestrate the inflammatory
process and foreign body reactions [20,21]. Their functions include
ingestion of bacteria by phagocytosis, destruction of bacteria
within the phagolysosome and recruitment of inflammatory cells
to the site of infection, using chemokines and acute-phase proteins.
It has been reported, however, that the presence of a biomaterial
may compromise the host immune system [22]. Therefore, it is
important to better understand how immune cells interact with
adhering pathogens.
In our previous work, the antimicrobial peptide Palm and the
enzyme DNase I were successfully co-immobilized onto PDMS sur-
faces to impart them with both anti-adhesive and antimicrobial
properties against the adhesion of relevant bacteria as single and
dual-species, with excellent stability and non-toxicity [23].
Although the results obtained were quite promising, it cannot be
neglected the fact that some bacteria managed to adhere to these
coatings. So, as a follow-up of this previous work, the goal of the
present study was to provide some insights about the potential
development of resistance by bacteria remaining on these func-
tionalized PDMS surfaces towards the antimicrobials immobilized.
It was also intended to investigate the role of these bi-functional
coatings on PDMS-adherent bacteria removal and digestion by
macrophages.2. Materials and methods
2.1. Bacterial strain and growth conditions
Staphylococcus aureus GB 2/1 isolated from explanted voice
prostheses at the University Medical Centre of Groningen (the
Netherlands) was used throughout this study. The strain was first
streaked on a tryptic soy agar (TSA, Liofilchem) plate from a frozen
stock solution and grown for 24 h at 37 C. For each experiment, a
few colonies were collected from the TSA plates and grown over-
night in batches of tryptic soy broth (TSB, Liofilchem) at 37 C
under agitation (120 rpm). Subsequently, cells were harvested by
centrifugation (9000g, 5 min) and washed in sterile saline solution
(0.9% NaCl prepared in ultrapure water). The concentration of cel-
lular suspensions was adjusted by optical density at 640 nm andcalibrated in terms of Colony Forming Units (CFU) using the spread
plate method.
2.2. AMP, enzyme and antibiotic
The enzyme DNase I and the antibiotic vancomycin were pur-
chased by AppliChem (Germany) and the AMP Palm-KGK-NH2
(Palm) was synthesized manually by solid-phase synthesis method
on polystyrene AM-RAM resin, using Fmoc/tButyl strategy as pre-
viously described [24]. Coupling was performed with HOBt/DIPCDI
method, the Fmoc protecting group were removed with 20% piperi-
dine. Crude peptides were cleaved from resin using a mixture of
trifluoroacetic acid (TFA), triisopropylsilane (TIS) and water as
scavengers. The final products were purified by reverse-phase high
performance liquid chromatography (RP-HPLC) in a mixture of ace-
tonitrile – water with 0.1% TFA as an eluent. Molecular weights of
peptides were determined by matrix – assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF).
2.3. Determination of minimal inhibitory and bactericidal
concentrations
The minimal inhibitory (MIC) and bactericidal (MBC) concentra-
tions of antimicrobials against S. aureus GB 2/1 were determined by
the microdilution method according to Clinical and Laboratory
Standards Institute (formerly NCCLS) [25]. Briefly, the wells of a
sterile 96-well round-bottom microtiter plates (polystyrene,
Orange, USA) were filled with 100 mL of MHB (Mueller-Hinton
broth) with increasing concentrations of antimicrobial to which
were added 100 mL of each bacterium inoculums (adjusted to a
final concentration of 5.0  105 CFUmL1). The plates were after-
wards incubated at 37 C for 24 h in an orbital shaker at 120
rpm. In this assay, two controls were used, one without bacteria
as a negative control and one without antimicrobials as a positive
control. Moreover, culture media with increasing concentrations of
antimicrobials without bacteria were also performed in order to
avoid misleading results. The MIC was obtained by measuring
the absorbance at 640 nm (A640nm), where clear wells (A640nm =
negative control) were evidence of bacterial growth inhibition.
MBC determination was performed by adding a droplet of 10 mL
from each well with no visible growth on a TSA plate. The lowest
concentration that yielded no colony growth after 24 h at 37 C
was identified as the MBC.
2.4. PDMS preparation and further functionalization
PDMS (kit Sylgard 184, Dow Corning, USA) was prepared and
functionalized with the lipopeptide Palm and enzyme DNase I as
previously described [23]. Briefly, the first step involved the depo-
sition of a polydopamine (pDA) coating onto PDMS coupons which
was performed by immersing them in 7 mL of a freshly prepared
solution of dopamine (Sigma, 2 mgmL1 dopamine-HCl in 10
mM bicine buffer, pH 8.5, Sigma) for 18 h at room temperature
(RT) and under agitation (70 rpm). Surfaces were then rinsed with
ultrapure water. For further functionalization, pDA-coated coupons
were immersed in a mixture solution composed of DNase I (1
mgmL1 in 150 mM NaCl, 10 mM potassium phosphate buffer
supplemented with 10 mM MgCl2, pH 6.8) and Palm (1 mgmL1
in PBS, pH 7.4) in a proportion of 1:3, respectively (MIX), and were
incubated for 6 h, at RT, under agitation (70 rpm).
2.5. Planktonic cultures exposure to a sub-lethal concentration of
antimicrobials
The potential development of resistance was first evaluated for
planktonic cells with antimicrobials in solution, following a proce-
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antimicrobial lipopeptide used to functionalize PDMS surfaces
together with the enzyme DNase I, a traditional antibiotic, often
used in clinical practice to fight BAI, vancomycin, was also investi-
gated in these tests for comparison purposes. Briefly, 40 lL of an
overnight culture of S. aureus GB 2/1 was inoculated in 20 mL of
TSB medium containing a sub-inhibitory concentration of Palm
(8 lgmL1) or vancomycin (0.125 lgmL1). The flask was then
incubated at 37 C and 120 rpm for 24 h. For 10 successive days,
similar and freshly prepared flasks were inoculated with 40 lL of
preceding days’ culture. The MIC and MBC of Palm and vancomycin
were determined, as previously described, on days 0 and 10. Two
independent assays were performed.
2.6. Evaluation of modified surfaces potential to induce bacterial
resistance
To evaluate the potential development of resistance of cells
adhered to the immobilized agents, a similar procedure to evaluate
the potential development of resistance in planktonic cultures was
performed, in which cells adhered to the surfaces with and without
modification were collected and placed in contact with new sur-
faces for 30 days. For comparison purposes, the antibiotic van-
comycin was immobilized onto PDMS using dopamine chemistry
(details of this immobilization can be found in Supplemental Mate-
rial, Figs. S1 and S2). Briefly, a bacterial suspension with 1  107
CFUmL1 was prepared in TSB and 300 mL of this suspension were
added to a 48-well microtiter plate in which PDMS, pDA, and pDA
further functionalized with Palm and DNase I (MIX) or vancomycin
(VANC) were placed. The plate was incubated for 3–4 days at 37 C
and 120 rpm, with TSB replacement every 1.5–2 days. The coupons
were subsequently washed with saline solution to remove free-
floating bacteria and transferred to an Eppendorf tube with 1 mL
of saline solution. The tubes were then sonicated for 6 min, sub-
jected to vortex for 30 s (these parameters were previously opti-
mized) and 300 mL of this suspension were added to a 48-well
microtiter plate in which new silicone coupons were placed. The
procedure was repeated for 30 successive days. The MIC and
MBC for each condition tested were determined after this period
and compared. Moreover, the transcript levels of some genes
involved in antimicrobial resistance and virulence mechanisms
were assessed using quantitative real time PCR (qRT-PCR). This
analysis was carried out for cells recovered from the different sur-
faces tested, being afterwards grown in solid media before RNA
extraction. Cells recovered from the control surfaces (PDMS and
pDA) were grown in TSA whereas cells retrieved from the surfaces
functionalized, PALM or VANC were grown in TSA supplemented
with a sub-inhibitory concentration of Palm and vancomycin,
respectively, to keep the stress conditions. The colonies recovered
from two replicated surfaces were pooled together in RNase free
water in order to reduce the variability associated with gene
expression quantification from biofilm samples [27], and cen-
trifuged to pellet before RNA extraction. Three independent exper-
iments in duplicate were performed.
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.actbio.2018.07.052.
2.7. Gene expression analysis
2.7.1. RNA extraction
RNA was extracted using the RNeasy mini kit (Qiagen) as previ-
ously optimized [28], with some modifications. Briefly, bacterial
pellets were suspended in 500 lL of Lysis buffer RLT (provided
by the kit) and 500 lL of phenol solution (AppliChem, Darmstadt)
and transferred to a 2 mL safe lock tube containing 0.4 g of
acid-washed 150–212 mm silica beads (Sigma). This mixture wasvortexed before using the FastPrepH cell disruptor (BIO 101,
Thermo Electron Corporation, Thermo Scientific) with the follow-
ing settings: 6.5 m s1 for 35 s. Samples were, afterwards, trans-
ferred to a new tube and mixed with equal volume of 70%
ethanol (Fisher Scientific). Finally, RNA elution was achieved by
adding 50 lL of RNase-free water to the centre of the membrane.
Following extraction, RNA was treated with DNase I (Thermo Sci-
entific) to digest possible contaminating genomic DNA, as previ-
ously described [28]. Briefly, 2 lL of DNase I and 5 lL of reaction
buffer were added to the RNA sample and incubated at 37 C for
30 min. Then, to inactivate the DNase I enzyme, 5 lL of 25 mM
EDTA was added to the mixture and incubated at 65 C for 10 min.
2.7.2. RNA quality determination
RNA samples concentration and purity were spectrophotomet-
rically determined using a NanoDrop 1000TM (Thermo Scientific).
The absorbance ratio A260/A280 was used as an indicator of pro-
tein contamination and A260/A230 as an indicator of polysaccha-
ride, phenol, and/or chaotropic salt contamination [29]. Gel
electrophoresis was used to assess the integrity of RNA samples
through visualization of the 23S/16S banding pattern. Elec-
trophoresis was carried out at 80 V for 60 min using a 1.5% agarose
gel. The gel was stained with GelRed and visualized using a Gel-
Doc2000 (Bio-Rad, Hercules, CA, US). RNA was stored at 80 C
for further use.
2.7.3. Gene expression quantification
For the quantification of gene expression by qPCR, total RNAwas
reverse transcribed to complementary DNA (cDNA) usingGRS cDNA
Synthesis Kit (Grisp) following the manufacturer’s instructions. The
same amount of total RNA (300 ng)was reverse transcribed in 10 lL
of reaction volume. The samples were incubated at 65 C for 5 min,
37 C for 60 min, and 70 C for 10 min. Random primers for the
amplification of 16S rRNA, a housekeeping gene, and specific viru-
lence genes (Table 1) were designed using the Primer3 software
[30], having as templates the genomeswith the following accession
number: CP009361.1. The qPCR reaction was prepared by mixing
together 5 mL of master MIX SYBR Xpert Fast SYBR (Grisp), 2 mL of
1:100 diluted cDNA, 0.5 mL of 5 mM forward and reverse primes
and water up to 10 mL. The efficiency of primers was determined
by the dilution method [31,32]. Quantitative RT-PCR run was per-
formed on a CFX 96 (Bio-Rad) with the following cycle parameters:
95 C for 3 min, 40 cycles of 95 C for 5 s and 60 C for 20 s. Quanti-
tative PCR products were analysed by melting curves for unspecific
products or primer dimer formation. Relative fold increase of speci-
fic mRNA transcripts, was determined by applying the Pfaffl equa-
tion [33] using 16S rRNA as reference gene. Data analysis was
based on three independent experiments.
2.8. Cells susceptibility to vancomycin chemotherapy
Cells susceptibility to vancomycin chemotherapy was evaluated
by determining their metabolic activity, using the XTT reduction
assay. Briefly, a bacterial suspension with 1  107 CFUmL1 was
prepared in TSB and 300 mL of this suspension were added to a
48-well microtiter plate in which coupons of unmodified PDMS,
pDA-coated PDMS (pDA) and pDA further functionalized with
DNase I and Palm (MIX) were placed. The plate was incubated
for 24 h at 37 C, under agitation (120 rpm). The coupons were
subsequently washed once with saline solution to remove free-
floating bacteria and 300 mL of vancomycin (MIC prepared in TSB)
was added to each well. As a control, 300 mL of TSB without antibi-
otic was also added. The plates were then incubated overnight at
37 C and 120 rpm, and metabolic activity was determined using
XTT reduction assay as previously described [34], with some mod-
ifications. This method is based on the reduction of XTT by
Table 1
Oligonucleotide sequences of the primers used for gene expression quantification by qPCR.
Target gene Direction Sequence (50 ? 30) Melting Temperature (C) Amplicon size (bp) Priming efficiency (%)
16S rRNA F GGTCTTGCTGTCACTTATAGATGG 59.2 164 90.4
R CGGAAGATTCCCTACTGCTG 59.8
walKR F TTGTCCGAAGATGAAGCAAG 59.0 248 93.7
R CGCAGTAACGAACGACGATA 59.9
vraSR F CCGGCAATATAACCTGCACT 60.0 220 111.7
R GTAGTTGCGACGGATGAGGT 60.0
mdeA F GCGAGAGGTGAAACGTTAGC 60.0 256 94.1
R AGAACAGAGCAGCAGCAACA 60.0
norA F CCACCTGCTCCTACTACAAACA 59.0 212 99.1
R ATGGAAAAGCCGTCAAGAGA 60.0
hla F ACCGCCAATTTTTCCAGAAT 60.7 167 98.6
R CCTGGCCTTCAGCATTTAAG 60.8
clpP F AACAACAAATCGCGGTGAAC 60.9 265 91.2
R TGCAGCCATACCGATACAAA 60.1
rpoB F AGTTCGTTCACCATCCGTTT 59.5 275 100.6
R CAGTGTTTTCAGTGCCGTCT 59.0
F, forward. R, reverse.
Table 2
Antimicrobial susceptibility of planktonic cultures of S. aureus GB 2/1 against Palm
and vancomycin: MIC and MBC on day 0 and after 10 passages in a sub-inhibitory
concentration. MIC and MBC are expressed in lg/mL.
Antimicrobial Day 0 Day 10
MIC MBC MIC MBC
Palm 64 64 128 128
Vancomycin 1 2 2 2
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produced formazan can be quantified by spectrophotometry anal-
ysis, being therefore proportional to the bacterial metabolic activ-
ity [35]. After biofilm growth and washing procedures as
aforementioned, 400 mL of a combined solution of XTT and phena-
zine methosulfate (PMS, Sigma) were added to each well in order
to obtain a final concentration of 150 mgmL1 of XTT and 10
mgmL1 of PMS. The plates were afterwards incubated at 37 C
for 3 h, at 120 rpm, in the dark. The absorbance of each well was
then measured at 490 nm using a microtiter plate reader. Two
independent assays with three replicates for each condition tested
were performed.
2.9. Macrophages adhesion to staphylococci adhering to surfaces
Prior to macrophages adhesion, staphylococci were allowed to
adhere to un- and modified surfaces. A bacterial suspension with
1  108 CFUmL1 was prepared in PBS from an overnight culture
at 37 C. PDMS coupons were then placed into the wells of a 48-
well tissue culture plate (Orange Scientific, USA) and covered with
300 mL of bacterial suspension. The samples were kept at 37 C and
120 rpm for 4 h. A human monocyte line cell (THP-1, ATCC TIB-
202) was used in this study. Monocytes were routinely cultured
in (RPMI-1640) with sodium bicarbonate and L-glutamine, supple-
mented with 10% FBS and 1% penicillin/streptomycin. The flasks
were kept at 37 C in a humidified atmosphere with 5% CO2 and
cells were passaged when reached the exponential phase of growth
(3–8  100 000 cellsmL1). Cells were harvested by centrifugation
(5 min at 150g) and the harvested cells were counted using a Bur-
ker–Turk hemocytometer. To induce monocytes differentiation
into macrophages, 1  106 cellsmL1 were diluted in RPMI supple-
mented with 100 nM of phorbol 12-Myristate 13 (PMA) and cul-
tured for 24 h at 37 C and 5% CO2. Cells in suspension were
afterwards removed by aseptically removing the medium and
adhered cells were washed with RPMI and incubated for more
48 h in medium without PMA. Cells were detached using trypsin
and 300 mL of a cell suspension with 5  105 cellsmL1 were added
to each well of a 48-well microtiter plate in which the modified
surfaces with staphylococci adhered as aforementioned were pre-
viously inserted. The plates were incubated at 37 C, 5% CO2 for 2 h.
As a control, modified surfaces with adhered staphylococci were
exposed to RPMI without macrophages. The coupons were washed
with PBS, stained with DAPI (40 mgmL1) and were visualized
under an epifluorescence microscope (Leica, DMI 3000B). An indi-
rect evaluation of bacteria phagocytosis was performed (details of
this analysis can be found in Supplemental Material, Fig. S3).2.10. Statistical analysis
Results were presented as mean ± standard deviation (SD). Sta-
tistical analysis was performed using Graph Pad Prism 7.0. To com-
pare gene expression levels, one-way ANOVA followed by Tukey’s
test was implemented. Metabolic activity of adhered cells with and
without vancomycin treatment was determined using a Two-way
ANOVA followed by Bonferroni’s test. In all the analysis performed,
the confidence interval used was 95%.3. Results
3.1. Potential development of resistance by planktonic cultures
towards Palm or vancomycin
The potential of Palm and vancomycin to induce microbial
resistance was first investigated when in solution against plank-
tonic cultures of S. aureus (Table 2). Results showed a 2-fold
increase in MIC and MBC of Palm and in the MIC of vancomycin
after 10 days of exposure, indicating that planktonic cultures of S.
aureus have become less susceptible to both antimicrobials. How-
ever, no changes on MBC of vancomycin were observed.3.2. Expression of genes associated to antimicrobial resistance and
virulence mechanisms
Quantitative RT-PCR analysis was implemented to deeply inves-
tigate whether the antimicrobials used to functionalize PDMS sur-
faces could exert any effect on the expression of genes associated
to antimicrobial resistance and virulence mechanisms. For this
analysis, 16s rRNA was used for normalization, and the outcomes
were formulated as fold-change levels relative to the colonies of
planktonic cultures (Fig. 1) and to the colonies of the cells recov-
ered from unmodified surfaces of PDMS (Fig. 2). The expression
level of two vancomycin resistance-associated genes, namely,
Fig. 1. Heat map of the relative transcription levels (comparing to the colonies of planktonic cultures) of the selected genes of adhered S. aureus GB 2/1 recovered from the
control surfaces (PDMS and pDA) and functionalized with vancomycin (VANC) and Palm together with DNase I (MIX), after different periods of exposure. Log2 fold change
higher than 1 indicates an increase in transcription levels while (red) while log2 fold change lower than 1 indicates a decrease in transcription levels (green). (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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the control surfaces (PDMS and pDA), were also upregulated in
the cells exposed to the functionalized surfaces and an increase
along time was observed, especially for the vraSR gene. Overex-
pression of these genes, in general, may be attributed to theFig. 2. Heat map of the relative transcription levels (comparing to the colonies of
cells recovered from PDMS surfaces on each period) of the selected genes of
adhered S. aureus GB 2/1 recovered from the surfaces functionalized with
vancomycin (VANC) and Palm together with DNase I (MIX), after different periods
of exposure. Log2 fold change higher than 1 indicates an increase in transcription
levels while (red) while log2 fold change lower than 1 indicates a decrease in
transcription levels (green). (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)transition from planktonic to an adherent state, which leads to
changes in gene expression [36]. Results showed no differences
on the expression level of rpoB on cells recovered from the control
surfaces when compared to the planktonic cultures and a similar
expression was found for cells recovered from both functionalized
surfaces. Furthermore, the expression of this gene was not influ-
enced by the exposure time.
The two genes investigated, encoding two different efflux
pumps, presented different expression profiles.mdeA gene, already
upregulated in the cells recovered from the control surfaces, was
also upregulated in the cells recovered from both functionalized
surfaces (VANC and MIX). Over time, a slight decrease on the tran-
scription of this gene was found, especially for the cells in contact
with MIX. Regarding norA gene, the transition of planktonic to an
adhered state had no effect on its transcription for the control sur-
faces. On the other hand, the expression levels of this gene were
greatly decreased for cells recovered from both functionalized sur-
faces. This downregulation, compared to the control surfaces (p <
0.05), was observed from the beginning until the end of the 30 days
of exposure, especially noticed, in the end, for the cells recovered
from MIX.
It was found no differences on the expression level of hla on
cells recovered from the control surfaces, when compared to the
planktonic cultures. On the other hand, both functionalized sur-
faces (VANC and MIX) should suppress alpha hemolysin produc-
tion by downregulating the expression of hla (P < 0.05) and this
downregulation was kept over time. Regarding the expression of
clpP, this one was found increased for the cells recovered from
the control surfaces (PDMS and pDA) over time, and a similar tran-
scription was found for the functionalized surfaces during the first
10 days of exposure. In the last days, however, an increase on the
expression levels of this gene for the cells in contact with VANC
was observed (Fig. 2).
3.3. Susceptibility patterns of cells recovered from surfaces
Cells in contact with unmodified and modified PDMS surfaces
were recovered after 30 days and used to determine the MIC and
MBC of Palm and vancomycin (Table 3). It was possible to conclude
that cells adhered to MIX exhibited the same susceptibility pat-
terns of cells permanently exposed to unmodified surfaces (PDMS
and pDA), suggesting no development of resistance. When it comes
Table 3
MIC and MBC range values of Palm and vancomycin against adhered S. aureus GB 2/1 recovered from unmodified PDMS, pDA, pDA functionalized with Palm and DNase I (MIX)
and pDA functionalized with vancomycin (VANC), after 30 days of exposure. MIC and MBC are expressed in lg/mL. ND means not determined and the presence of some colonies
found for some concentrations are denoted in brackets.
Antimicrobial MIC MBC
PDMS pDA MIX VANC PDMS pDA MIX VANC
Palm 32–128 32–128 32–128 ND 64–128 64–128 64–128 ND
Vancomycin 1–2 1–2 ND 1–2 2–8 (16) 4–16 ND 4–16 (32)
194 D.F. Alves et al. / Acta Biomaterialia 78 (2018) 189–197to cells exposed to VANC, they exhibited the same MIC values as
the cells recovered from the control surfaces. MBC determination
suggested the presence of heteroresistant or tolerant sub-
populations, as some colonies could grow for some of the highest
concentrations of vancomycin tested (denoted in brackets in
Table 3). This phenomenon was observed on cells in contact with
vancomycin but also on cells from the control surfaces (PDMS),
so it cannot be merely attributed to the continuous pressure
exerted by the immobilized antibiotic. Since a clinical isolate was
used, the probability of being a heteroresistant or tolerant strain
is higher [37].
3.4. Susceptibility of cells adhered to modified surfaces to vancomycin
chemotherapy
To evaluate the susceptibility of cells adhered on MIX, these
were subjected to vancomycin treatment overnight. Fig. 3 shows
that, in the absence of treatment, the cells that managed to adhere
to both unmodified and modified surfaces could grow exhibiting a
higher metabolic activity. Vancomycin treatment had no effect on
cells metabolic activity when these were allowed to adhere to
unmodified PDMS or pDA. On the other hand, cells found adhered
to MIX were more susceptible to antibiotic treatment, as evidenced
by the decrease on their metabolic activity, suggesting a synergis-
tic effect between modified surfaces and antibiotic therapy.
3.5. Macrophages phagocytosis of adhered cells
Phagocytosis of staphylococci by macrophages on unmodified
modified surfaces was evaluated by an indirect method based on
a previously reported method [21]. After allowing bacterial adhe-
sion for 4 h to the different surfaces (Fig. 4A–C), it was possible
to observe that the number of adhered bacteria to functionalized
surface MIX was lower than on control surfaces, corroborating pre-
vious findings [23]. After 2 h exposure to RPMI media withoutFig. 3. Metabolic activity of cells of S. aureus GB 2/1 adhered to unmodified PDMS,
pDA-coated PDMS (pDA) and pDA-coated PDMS surfaces functionalized with DNase
I and Palm (MIX), after being subjected to no treatment (black) or vancomycin
treatment at its MIC (white). Significant differences were found for MIX (***)
p < 0.001, compared to No treatment.macrophages, the fraction of adhered bacteria to PDMS slightly
increased (Fig. 4D) whereas some detachment was observed for
bacteria adhered to pDA-coated surfaces (Fig. 4E) which may be
attributed to the hydrophilic features characteristic of this surface
[38]. Cells adhered to MIX surface were not detached when
exposed to solely RPMI (Fig. 4F). After macrophages contact with
adhered staphylococci (Fig. 4G–I), significant reductions were
found for all the surfaces, as compared to control RPMI, which is
an indirect indication of bacterial phagocytosis [21]. These obser-
vations were confirmed by using ImageJ software to evaluate the
attachment of staphylococci for all the conditions tested (see
Fig. S3 of Supplementary Material). Results also showed that
macrophages adhesion to unmodified PDMS tend to cluster while
after pDA coating these cells were found more evenly distributed
along the surfaces.
4. Discussion
In the fight against BAI, several surface modifications have been
proposed to render the biomaterial surfaces with anti-infective
properties [39]. Despite the promising results reported in the liter-
ature, where reductions on bacterial attachment higher than 90%
are often achieved [17], most of these approaches tend to disregard
the fate of the few bacteria that manage to attach to these modified
surfaces. In our previous work, the co-immobilization of DNase I
and Palm onto PDMS yielded a promising coating strategy with
excellent anti-adhesive and antimicrobial properties without cyto-
toxicity [23]. However, it could not be neglected the fact that some
bacteria managed to adhere to these coatings.
Bacteria have a striking ability to adapt in response to their
environment, and in fact, some bacterial strains are not susceptible
to some AMP in solution, even at high concentrations [40,41].
Results with planktonic cultures continuously exposed to a sub-
inhibitory concentration of Palm also suggested some resistance
towards the AMP in solution, evidenced by the 2-fold increase in
MIC and MBC. In theory, compounds immobilization, without
leaching, should decrease its propensity to induce bacterial resis-
tance as there is no exposure to sub-inhibitory concentrations
[19]. In fact, results found in this study suggested that both com-
pounds immobilized on the surfaces (Palm and Vancomycin)
exhibited a low propensity to develop bacterial resistance after a
long period of exposure, 30 days.
Cell wall thickening is one of the molecular mechanisms of
strains resistant to antimicrobials targeting the cell wall, such as
vancomycin and antimicrobial peptides [42]. Therefore, three
genes involved in this mechanism were first investigated. The
two-component regulator system VraSR is known to upregulate
the expression of enzymes involved in the peptidoglycan synthesis
pathway [43] while the WalKR system plays a role in the regula-
tion of cell wall metabolism-associated genes, specifically as a reg-
ulator of peptidoglycan biosynthesis during cross bridge hydrolysis
[44]. Overexpression of vraSR activates the expression of a cluster
of genes called the ‘‘cell-wall stimulon”, which positively regulate
synthesis of the cell wall, causing its thickening, thus increasing
the resistance towards antimicrobials targeting the cell wall [43].
Fig. 4. DAPI-stained images of S. aureus GB 2/1 adhesion to unmodified PDMS (A, D and G), pDA-coated PDMS (pDA, B, E and H) and pDA-coated PDMS surfaces functionalized
with Palm and DNase I (MIX, C, F and I). First, bacteria were allowed to adhere for 4 h (A-C) being afterwards exposed for 2 h to RPMI without () (D–F) and with (+) (G–I)
macrophages. The scale bar denotes 100 lm.
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increased resistance to vancomycin, probably through regulation
of cell wall metabolism [44,45]. The gene encoding DNA-
dependent RNA polymerase b-subunit (rpoB) is also commonly
associated with increased resistance to vancomycin and increase
cell wall thickness [46,47]. The expression levels of genes walKR
and vraSRwere upregulated in the cells recovered from the control
surfaces (PDMS and pDA), from the beginning until the end of the
assay. Such profiles should be expected as the cells recovered from
these surfaces had the necessary conditions to form biofilms,
which have distinct patterns of gene expression as compared to
their planktonic counterparts [36]. On the other hand, no differ-
ences were found on the expression level of rpoB cells recovered
from the control surfaces as compared to planktonic cultures, but
a similar expression was observed for the cells exposed to the
immobilized compounds.
Another mechanism used by bacteria to resist antimicrobials
includes the upregulation of multi-drug resistant efflux pumps that
include these compounds within their substrate profiles being
responsible for their efflux from the cells [48]. Although the
antimicrobials immobilized on the surfaces cannot be extruded
by these pumps, it is important to investigate the expression of
genes encoding these pumps to better understand the susceptibil-
ity of the cells adhered onto antimicrobial surfaces to a potential
antimicrobial treatment. Continuous exposure to the functional-
ized surfaces altered the expression of norA gene, namely causing
its downregulation while no difference was observed on expres-
sion profiles of mdeA as compared to control surfaces.
Finally, the expression profile of known virulence related genes,
namely clpP and hla, was also addressed. Alpha-hemolysin, also
called alpha toxin, encoded by hla gene, is a protein which inser-
tion into host cell membranes results in their lysis [49]. The prote-olytic subunit of the ATP-dependent Clp protease (ClpP) is encoded
by ClpP gene. ClpP complexes are responsible for adaptation to sev-
eral stress conditions by degrading accumulated and misfolded
proteins, playing a crucial role in the survival and virulence of
pathogens such as S. aureus [50,51]. A downregulation of the
expression of hla gene was found for the cells recovered from the
functionalized surfaces while no difference was found on the
expression profiles of clpP as compared to control surfaces.
Overall, the expression analysis did not point out any develop-
ment of resistance, since cells in contact with modified surfaces
exhibited some genes involved in microbial resistance equally or
less expressed, as compared to the ones recovered from control
surfaces. The susceptibility patterns found for these cells also cor-
roborated these findings.
Once a BAI is established, the most common approach of treat-
ment involves the use of antibiotics, which dose must be higher
than their MIC to be able to affect cells in sessile style [52]. Accord-
ingly, in the present study, cells adhered to unmodified PDMS and
pDA were not influenced by vancomycin treatment at its MIC. In
the absence of treatment, cells adhered to modified surfaces exhib-
ited a similar metabolic activity as those found on unmodified sur-
faces. These results suggest that bi-functional coatings alone may
not be sufficient to effectively prevent BAI, when a complex and
rich media such as TSB is used. When combined with vancomycin
treatment, however, even using a lower concentration, S. aureus
metabolic activity was significantly impaired on MIX. These results
point out that antibiotic treatment of BAI could be more effective
when these infections occurs after the implantation of a biomate-
rial holding this functional coating [53]. Enhanced bacterial sus-
ceptibility to antibiotic therapy may be attributed to the
antimicrobial activity conferred by Palm immobilization. A similar
mechanism of antimicrobial activity for immobilized quaternary
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charged surfaces, in general, has been proposed [54]. The authors
showed that immobilized QAC-molecules enhanced the adhesion
forces between bacteria and a surface to a lethally strong attrac-
tion, causing reduced growth, stress-induced deactivation and
eventually leading to cell death. Since most of bacterial strains
and species exhibit a negative surface charge [55], it is believed
that strong adhesion forces can also be found on surfaces function-
alized with cationic AMP that has proved to kill bacteria upon con-
tact, in a so called ‘‘lethal” regime of strong adhesion forces [53].
Another factor that may have contributed to this higher suscepti-
bility is associated to norA downregulation found for cells exposed
to functionalized surfaces (VAN and MIX), which was kept over
time. Although the expression of norA has been mainly associated
with increased tolerance and efflux of a wide variety of structurally
unrelated compounds (hydrophilic fluoroquinolones, benzalko-
nium, ethidium bromide and rhodamine) that does not include
vancomycin, [48] the expression of the Nor-family efflux pumps
is not fully understood and is likely influenced by several of host
and environmental conditions [56,57]. Indeed, Kong et al. have
reported that S. aureus tolerance to vancomycin treatment was
attributed to upregulation of this drug efflux pump [57].
Upon the implantation of a biomaterial, tissue trauma and
injury trigger a cascade of physiological events that activate the
immune system [58]. The interactions between macrophages and
bacterially contaminated biomaterials is, therefore, crucial for the
establishment of a BAI. Indeed, mature biofilms are less likely to
form if macrophages can remove and destroy bacteria adhering
on a biomaterial surface. For further evaluation of the clinical
potential of our bi-functional coating previously proposed [23]
the in vitro response of human macrophages to S. aureus adhering
to these coatings was also investigated and compared to unmodi-
fied surfaces. Results showed that macrophages were better dis-
tributed along pDA surfaces which suggests a better mobility to
perform their phagocytic activity. In a previous study, on the inter-
action between macrophages and colonizing S. epidermidis, it was
shown that macrophage behavior is surface dependent and macro-
phages on cross-linked PEG-based coatings exhibited enhanced
cell motility compared to the motility on silicone rubber and glass
[59]. Comparison of bacterial attachment on surfaces exposed to
macrophages and RPMI media alone revealed a higher reduction
on bacterial adhered to the surfaces in the presence of macro-
phages, an indirect indication of bacterial phagocytosis [21].
Results highlight that functionalization of PDMS with Palm and
DNase I should not compromise the action of host immune cells
which is a desirable feature for any coating strategy since some
previous studies have demonstrated that immune cells may lose
their ability to kill bacteria in the presence of a biomaterial [60,61].5. Conclusions
In conclusion, the small fraction of bacteria found adhered onto
our antibacterial surfaces previously proposed [23] did not develop
resistance towards the compounds immobilized, being even more
susceptible to vancomycin chemotherapy. Modified surfaces did
not compromise the action of host immune cells. Overall results
added value to this antimicrobial coating strategy, as a good candi-
date for in vivo assays and its ultimate clinical application.Acknowledgements
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